Sound waves aimed at the brain could tame seizures

NCT ID NCT06388707

First seen Apr 14, 2026 · Last updated Jun 22, 2026 · Updated 11 times

Summary

This early study tests a device that uses low-intensity focused ultrasound to calm overactive brain areas in people with drug-resistant temporal lobe epilepsy. Eight adults will receive up to three 10-minute ultrasound sessions. Researchers will track side effects and check if seizure frequency changes. The goal is to see if this non-invasive approach is safe and worth studying further.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Brigham and Women's Hospital

    RECRUITING

    Boston, Massachusetts, 02115, United States

    Contact

  • Stanford University School of Medicine

    RECRUITING

    Palo Alto, California, 94305, United States

    Contact

  • University of Virginia School of Medicine

    RECRUITING

    Charlottesville, Virginia, 22903, United States

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

low-intensity focused ultrasound (LIFU) device

What this could lead to

If it works, this could point toward a non-invasive treatment option for people with drug-resistant epilepsy, potentially reducing seizure frequency without surgery.

What could go wrong

This is a very small, early pilot study with only 8 participants, so results may not apply widely. The treatment is still experimental, and safety and effectiveness are not yet proven.

Conditions

The condition(s) this trial relates to.

Drug Resistant Epilepsy epilepsy visual epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.